Search details
1.
Effects of the ACTIVity And TEchnology (ACTIVATE) intervention on health-related quality of life and fatigue outcomes in breast cancer survivors.
Psychooncology
; 29(1): 204-211, 2020 01.
Article
in English
| MEDLINE | ID: mdl-31763746
2.
Restorative Narratives for Health Promotion.
Health Commun
; 35(3): 356-363, 2020 03.
Article
in English
| MEDLINE | ID: mdl-30614737
3.
Maintenance of physical activity and sedentary behavior change, and physical activity and sedentary behavior change after an abridged intervention: Secondary outcomes from the ACTIVATE Trial.
Cancer
; 125(16): 2856-2860, 2019 08 15.
Article
in English
| MEDLINE | ID: mdl-31012968
4.
A randomized controlled trial of a wearable technology-based intervention for increasing moderate to vigorous physical activity and reducing sedentary behavior in breast cancer survivors: The ACTIVATE Trial.
Cancer
; 125(16): 2846-2855, 2019 08 15.
Article
in English
| MEDLINE | ID: mdl-31012970
5.
A qualitative evaluation of breast cancer survivors' acceptance of and preferences for consumer wearable technology activity trackers.
Support Care Cancer
; 25(11): 3375-3384, 2017 11.
Article
in English
| MEDLINE | ID: mdl-28540402
6.
Miliary EGFR mutated non-small cell lung cancer.
Med J Aust
; 214(3): 118, 2021 02.
Article
in English
| MEDLINE | ID: mdl-33462827
7.
Estimating cancers attributable to physical inactivity in Australia.
J Sci Med Sport
; 27(3): 149-153, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38103985
8.
Linking Physical Activity to Breast Cancer Risk via Inflammation, Part 1: The Effect of Physical Activity on Inflammation.
Cancer Epidemiol Biomarkers Prev
; 32(5): 588-596, 2023 05 01.
Article
in English
| MEDLINE | ID: mdl-36867865
9.
Linking Physical Activity to Breast Cancer via Inflammation, Part 2: The Effect of Inflammation on Breast Cancer Risk.
Cancer Epidemiol Biomarkers Prev
; 32(5): 597-605, 2023 05 01.
Article
in English
| MEDLINE | ID: mdl-36867866
10.
Linking Physical Activity to Breast Cancer: Text Mining Results and a Protocol for Systematically Reviewing Three Potential Mechanistic Pathways.
Cancer Epidemiol Biomarkers Prev
; 31(1): 11-15, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34670802
11.
Linking Physical Activity to Breast Cancer Risk via the Insulin/Insulin-like Growth Factor Signaling System, Part 2: The Effect of Insulin/Insulin-like Growth Factor Signaling on Breast Cancer Risk.
Cancer Epidemiol Biomarkers Prev
; 31(12): 2116-2125, 2022 12 05.
Article
in English
| MEDLINE | ID: mdl-36464995
12.
Linking Physical Activity to Breast Cancer Risk via Insulin/Insulin-Like Growth Factor Signaling System, Part 1: The Effect of Physical Activity on the Insulin/Insulin-Like Growth Factor Signaling System.
Cancer Epidemiol Biomarkers Prev
; 31(12): 2106-2115, 2022 12 05.
Article
in English
| MEDLINE | ID: mdl-36464996
13.
Linking Physical Activity to Breast Cancer via Sex Hormones, Part 1: The Effect of Physical Activity on Sex Steroid Hormones.
Cancer Epidemiol Biomarkers Prev
; 31(1): 16-27, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34670800
14.
Linking Physical Activity to Breast Cancer via Sex Steroid Hormones, Part 2: The Effect of Sex Steroid Hormones on Breast Cancer Risk.
Cancer Epidemiol Biomarkers Prev
; 31(1): 28-37, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34670801
15.
Effects of a wearable technology-based physical activity intervention on sleep quality in breast cancer survivors: the ACTIVATE Trial.
J Cancer Surviv
; 15(2): 273-280, 2021 04.
Article
in English
| MEDLINE | ID: mdl-32875536
16.
Response to letter from Geoffrey W. Stuart.
J Sci Med Sport
; 27(6): 386, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38614843
17.
Study design and methods for the ACTIVity And TEchnology (ACTIVATE) trial.
Contemp Clin Trials
; 64: 112-117, 2018 01.
Article
in English
| MEDLINE | ID: mdl-29097298
18.
EGFR and KRAS mutations do not enrich for the activation of IL-6, JAK1 or phosphorylated STAT3 in resected lung adenocarcinoma.
Med Oncol
; 34(10): 175, 2017 Sep 06.
Article
in English
| MEDLINE | ID: mdl-28879441
19.
The clinical relevance of pathologic subtypes in metastatic lung adenocarcinoma.
J Thorac Oncol
; 9(5): 654-63, 2014 May.
Article
in English
| MEDLINE | ID: mdl-24722155
20.
EGFR gene copy number alterations are not a useful screening tool for predicting EGFR mutation status in lung adenocarcinoma.
Pathology
; 46(1): 32-6, 2014 Jan.
Article
in English
| MEDLINE | ID: mdl-24300726